Pre-Treatment Tumor Growth Rate (TGR0) in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) Treated with Systemic Therapies: Subgroup Analysis of the GREPONET Study

Conference contribution


Publication Details

Author(s): Crona J, Lamarca A, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Vidal Trueba H, Carvhalo L, De Mestier L, Najran P, Pavel ME, Dromain C
Publication year: 2018
Volume: 106
Pages range: 171-171
ISSN: 0028-3835


FAU Authors / FAU Editors

Pavel, Marianne Ellen
Professur für Endokrinologie


External institutions with authors

Beaujon Hospital / Hôpital Beaujon
Christie NHS Foundation Trust
Hospital Israelita Albert Einstein
Hospital Sírio-Libanês
Hospital Universitario de Marqués de Valdecilla (HUMV)
Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV)
The University Hospital in Krakow
Uppsala University


How to cite

APA:
Crona, J., Lamarca, A., Ronot, M., Opalinska, M., Lopez Lopez, C., Pezzutti, D.,... Dromain, C. (2018). Pre-Treatment Tumor Growth Rate (TGR0) in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) Treated with Systemic Therapies: Subgroup Analysis of the GREPONET Study. (pp. 171-171).

MLA:
Crona, J., et al. "Pre-Treatment Tumor Growth Rate (TGR0) in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) Treated with Systemic Therapies: Subgroup Analysis of the GREPONET Study." 2018. 171-171.

BibTeX: 

Last updated on 2019-29-08 at 07:10